img

Global Geriatric Medicines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Geriatric Medicines Market Insights, Forecast to 2034

Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.
Market Analysis and InsightsGlobal Geriatric Medicines Market
Global Geriatric Medicines market is expected to reach to US$ 762320 million in 2023, with a positive growth of %, compared with US$ 712450 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Geriatric Medicines industry is evaluated to reach US$ 1150460 million in 2033. The CAGR will be 7.1% during 2023 to 2033.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
Report Covers
This report presents an overview of global Geriatric Medicines market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Geriatric Medicines market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants

Segment by Application


Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Geriatric Medicines introduction, etc. Geriatric Medicines Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Geriatric Medicines
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotics
1.2.9 Antidepressants
1.3 Market by Application
1.3.1 Global Geriatric Medicines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Cardiovascular diseases
1.3.3 Arthritis
1.3.4 Neurological Disorders
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicines Market Perspective (2018-2033)
2.2 Global Geriatric Medicines Growth Trends by Region
2.2.1 Geriatric Medicines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Geriatric Medicines Historic Market Size by Region (2018-2023)
2.2.3 Geriatric Medicines Forecasted Market Size by Region (2024-2033)
2.3 Geriatric Medicines Market Dynamics
2.3.1 Geriatric Medicines Industry Trends
2.3.2 Geriatric Medicines Market Drivers
2.3.3 Geriatric Medicines Market Challenges
2.3.4 Geriatric Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Geriatric Medicines by Players
3.1.1 Global Geriatric Medicines Revenue by Players (2018-2023)
3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Geriatric Medicines, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Geriatric Medicines Market Concentration Ratio
3.4.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2022
3.5 Global Key Players of Geriatric Medicines Head office and Area Served
3.6 Global Key Players of Geriatric Medicines, Product and Application
3.7 Global Key Players of Geriatric Medicines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicines Breakdown Data by Type
4.1 Global Geriatric Medicines Historic Market Size by Type (2018-2023)
4.2 Global Geriatric Medicines Forecasted Market Size by Type (2024-2033)
5 Geriatric Medicines Breakdown Data by Application
5.1 Global Geriatric Medicines Historic Market Size by Application (2018-2023)
5.2 Global Geriatric Medicines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Geriatric Medicines Market Size (2018-2033)
6.2 North America Geriatric Medicines Market Size by Type
6.2.1 North America Geriatric Medicines Market Size by Type (2018-2023)
6.2.2 North America Geriatric Medicines Market Size by Type (2024-2033)
6.2.3 North America Geriatric Medicines Market Share by Type (2018-2033)
6.3 North America Geriatric Medicines Market Size by Application
6.3.1 North America Geriatric Medicines Market Size by Application (2018-2023)
6.3.2 North America Geriatric Medicines Market Size by Application (2024-2033)
6.3.3 North America Geriatric Medicines Market Share by Application (2018-2033)
6.4 North America Geriatric Medicines Market Size by Country
6.4.1 North America Geriatric Medicines Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Geriatric Medicines Market Size by Country (2018-2023)
6.4.3 North America Geriatric Medicines Market Size by Country (2024-2033)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Geriatric Medicines Market Size (2018-2033)
7.2 Europe Geriatric Medicines Market Size by Type
7.2.1 Europe Geriatric Medicines Market Size by Type (2018-2023)
7.2.2 Europe Geriatric Medicines Market Size by Type (2024-2033)
7.2.3 Europe Geriatric Medicines Market Share by Type (2018-2033)
7.3 Europe Geriatric Medicines Market Size by Application
7.3.1 Europe Geriatric Medicines Market Size by Application (2018-2023)
7.3.2 Europe Geriatric Medicines Market Size by Application (2024-2033)
7.3.3 Europe Geriatric Medicines Market Share by Application (2018-2033)
7.4 Europe Geriatric Medicines Market Size by Country
7.4.1 Europe Geriatric Medicines Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Geriatric Medicines Market Size by Country (2018-2023)
7.4.3 Europe Geriatric Medicines Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Geriatric Medicines Market Size (2018-2033)
8.2 China Geriatric Medicines Market Size by Type
8.2.1 China Geriatric Medicines Market Size by Type (2018-2023)
8.2.2 China Geriatric Medicines Market Size by Type (2024-2033)
8.2.3 China Geriatric Medicines Market Share by Type (2018-2033)
8.3 China Geriatric Medicines Market Size by Application
8.3.1 China Geriatric Medicines Market Size by Application (2018-2023)
8.3.2 China Geriatric Medicines Market Size by Application (2024-2033)
8.3.3 China Geriatric Medicines Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Geriatric Medicines Market Size (2018-2033)
9.2 Asia Geriatric Medicines Market Size by Type
9.2.1 Asia Geriatric Medicines Market Size by Type (2018-2023)
9.2.2 Asia Geriatric Medicines Market Size by Type (2024-2033)
9.2.3 Asia Geriatric Medicines Market Share by Type (2018-2033)
9.3 Asia Geriatric Medicines Market Size by Application
9.3.1 Asia Geriatric Medicines Market Size by Application (2018-2023)
9.3.2 Asia Geriatric Medicines Market Size by Application (2024-2033)
9.3.3 Asia Geriatric Medicines Market Share by Application (2018-2033)
9.4 Asia Geriatric Medicines Market Size by Region
9.4.1 Asia Geriatric Medicines Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Geriatric Medicines Market Size by Region (2018-2023)
9.4.3 Asia Geriatric Medicines Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Geriatric Medicines Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Type
10.2.1 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Geriatric Medicines Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Application
10.3.1 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Geriatric Medicines Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Country
10.4.1 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Geriatric Medicines Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Geriatric Medicines Introduction
11.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2018-2023)
11.1.5 Eli Lilly and Company Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Geriatric Medicines Introduction
11.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2018-2023)
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
11.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Geriatric Medicines Introduction
11.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2018-2023)
11.4.5 Abbott Laboratories Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Geriatric Medicines Introduction
11.5.4 Sanofi Revenue in Geriatric Medicines Business (2018-2023)
11.5.5 Sanofi Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Geriatric Medicines Introduction
11.7.4 Merck Revenue in Geriatric Medicines Business (2018-2023)
11.7.5 Merck Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Geriatric Medicines Introduction
11.8.4 Novartis Revenue in Geriatric Medicines Business (2018-2023)
11.8.5 Novartis Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Geriatric Medicines Introduction
11.9.4 Pfizer Revenue in Geriatric Medicines Business (2018-2023)
11.9.5 Pfizer Recent Developments
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Geriatric Medicines Introduction
11.10.4 GSK Revenue in Geriatric Medicines Business (2018-2023)
11.10.5 GSK Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Geriatric Medicines Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotics
Table 9. Key Players of Antidepressants
Table 10. Global Geriatric Medicines Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 11. Global Geriatric Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Geriatric Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Geriatric Medicines Market Share by Region (2018-2023)
Table 14. Global Geriatric Medicines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Geriatric Medicines Market Share by Region (2024-2033)
Table 16. Geriatric Medicines Market Trends
Table 17. Geriatric Medicines Market Drivers
Table 18. Geriatric Medicines Market Challenges
Table 19. Geriatric Medicines Market Restraints
Table 20. Global Geriatric Medicines Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Geriatric Medicines Revenue Share by Players (2018-2023)
Table 22. Global Top Geriatric Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
Table 23. Global Geriatric Medicines Industry Ranking 2021 VS 2022 VS 2023
Table 24. Global 5 Largest Players Market Share by Geriatric Medicines Revenue (CR5 and HHI) & (2018-2023)
Table 25. Global Key Players of Geriatric Medicines, Headquarters and Area Served
Table 26. Global Key Players of Geriatric Medicines, Product and Application
Table 27. Global Key Players of Geriatric Medicines, Product and Application
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Geriatric Medicines Revenue Market Share by Type (2018-2023)
Table 31. Global Geriatric Medicines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Geriatric Medicines Revenue Market Share by Type (2024-2033)
Table 33. Global Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Geriatric Medicines Revenue Share by Application (2018-2023)
Table 35. Global Geriatric Medicines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Geriatric Medicines Revenue Share by Application (2024-2033)
Table 37. North America Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 38. North America Geriatric Medicines Market Size by Type (2024-2033) & (US$ Million)
Table 39. North America Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 40. North America Geriatric Medicines Market Size by Application (2024-2033) & (US$ Million)
Table 41. North America Geriatric Medicines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. North America Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 43. North America Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 44. Europe Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 45. Europe Geriatric Medicines Market Size by Type (2024-2033) & (US$ Million)
Table 46. Europe Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 47. Europe Geriatric Medicines Market Size by Application (2024-2033) & (US$ Million)
Table 48. Europe Geriatric Medicines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Europe Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 50. Europe Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 51. China Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 52. China Geriatric Medicines Market Size by Type (2024-2033) & (US$ Million)
Table 53. China Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 54. China Geriatric Medicines Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 56. Asia Geriatric Medicines Market Size by Type (2024-2033) & (US$ Million)
Table 57. Asia Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 58. Asia Geriatric Medicines Market Size by Application (2024-2033) & (US$ Million)
Table 59. Asia Geriatric Medicines Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 60. Asia Geriatric Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 61. Asia Geriatric Medicines Market Size by Region (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Geriatric Medicines Market Size by Type (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Geriatric Medicines Market Size by Application (2024-2033) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Geriatric Medicines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 67. Middle East, Africa, and Latin America Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 69. Eli Lilly and Company Company Details
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Geriatric Medicines Product
Table 72. Eli Lilly and Company Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 73. Eli Lilly and Company Recent Developments
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Geriatric Medicines Product
Table 77. AstraZeneca Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 78. AstraZeneca Recent Developments
Table 79. Boehringer Ingelheim Company Details
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Geriatric Medicines Product
Table 82. Boehringer Ingelheim Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 83. Boehringer Ingelheim Recent Developments
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Geriatric Medicines Product
Table 87. Abbott Laboratories Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 88. Abbott Laboratories Recent Developments
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Geriatric Medicines Product
Table 92. Sanofi Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 93. Sanofi Recent Developments
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Geriatric Medicines Product
Table 97. Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Geriatric Medicines Product
Table 102. Merck Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Geriatric Medicines Product
Table 107. Novartis Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 108. Novartis Recent Developments
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Geriatric Medicines Product
Table 112. Pfizer Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 113. Pfizer Recent Developments
Table 114. GSK Company Details
Table 115. GSK Business Overview
Table 116. GSK Geriatric Medicines Product
Table 117. GSK Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 118. GSK Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicines Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Geriatric Medicines Market Share by Type: 2022 VS 2033
Figure 3. Analgesics Features
Figure 4. Antihypertensives Features
Figure 5. Statins Features
Figure 6. Antidiabetics Features
Figure 7. Proton Pump Inhibitor Features
Figure 8. Anticoagulant Features
Figure 9. Antipsychotics Features
Figure 10. Antidepressants Features
Figure 11. Global Geriatric Medicines Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 12. Global Geriatric Medicines Market Share by Application: 2022 VS 2033
Figure 13. Cardiovascular diseases Case Studies
Figure 14. Arthritis Case Studies
Figure 15. Neurological Disorders Case Studies
Figure 16. Cancer Case Studies
Figure 17. Osteoporosis Case Studies
Figure 18. Respiratory Case Studies
Figure 19. Other Case Studies
Figure 20. Geriatric Medicines Report Years Considered
Figure 21. Global Geriatric Medicines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 22. Global Geriatric Medicines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 23. Global Geriatric Medicines Market Share by Region: 2022 VS 2033
Figure 24. Global Geriatric Medicines Market Share by Players in 2022
Figure 25. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
Figure 26. The Top 10 and 5 Players Market Share by Geriatric Medicines Revenue in 2022
Figure 27. North America Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. North America Geriatric Medicines Market Share by Type (2018-2033)
Figure 29. North America Geriatric Medicines Market Share by Application (2018-2033)
Figure 30. North America Geriatric Medicines Market Share by Country (2018-2033)
Figure 31. United States Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Canada Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Europe Geriatric Medicines Market Size YoY (2018-2033) & (US$ Million)
Figure 34. Europe Geriatric Medicines Market Share by Type (2018-2033)
Figure 35. Europe Geriatric Medicines Market Share by Application (2018-2033)
Figure 36. Europe Geriatric Medicines Market Share by Country (2018-2033)
Figure 37. Germany Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. France Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. U.K. Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Italy Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Russia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Nordic Countries Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Geriatric Medicines Market Size YoY (2018-2033) & (US$ Million)
Figure 44. China Geriatric Medicines Market Share by Type (2018-2033)
Figure 45. China Geriatric Medicines Market Share by Application (2018-2033)
Figure 46. Asia Geriatric Medicines Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Asia Geriatric Medicines Market Share by Type (2018-2033)
Figure 48. Asia Geriatric Medicines Market Share by Application (2018-2033)
Figure 49. Asia Geriatric Medicines Market Share by Region (2018-2033)
Figure 50. Japan Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. South Korea Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. China Taiwan Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Southeast Asia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. India Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Australia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Middle East, Africa, and Latin America Geriatric Medicines Market Size YoY (2018-2033) & (US$ Million)
Figure 57. Middle East, Africa, and Latin America Geriatric Medicines Market Share by Type (2018-2033)
Figure 58. Middle East, Africa, and Latin America Geriatric Medicines Market Share by Application (2018-2033)
Figure 59. Middle East, Africa, and Latin America Geriatric Medicines Market Share by Country (2018-2033)
Figure 60. Brazil Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Mexico Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. Turkey Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 63. Saudi Arabia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 64. Israel Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 65. GCC Countries Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 67. AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 69. Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 70. Sanofi Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 72. Merck Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 73. Novartis Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 74. Pfizer Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 75. GSK Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries